R P Hayes

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. doi Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Diabetes 5:358-67. 2013
  2. pmc Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Lars Viktrup
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    BMC Urol 12:30. 2012
  3. doi Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA
    Diabetes Technol Ther 14:1118-25. 2012
  4. pmc Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
    Kristina Secnik Boye
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Health Qual Life Outcomes 4:80. 2006
  5. pmc Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
    Mallik Angalakuditi
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, IN, USA
    Health Qual Life Outcomes 8:131. 2010
  6. pmc Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
    R P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA
    Int J Clin Pract 62:860-8. 2008
  7. doi Perceptions and attitudes are primary contributors to insulin delivery system satisfaction in people with type 2 diabetes
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 11:419-26. 2009
  8. doi The contribution of pretreatment expectations and expectation-perception difference to change in treatment satisfaction and end point treatment satisfaction in the context of initiation of inhaled insulin therapy in patients with type 2 diabetes
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 12:447-53. 2010
  9. doi Ability to perform daily physical activities in individuals with type 2 diabetes and moderate obesity: a preliminary validation of the Impact of Weight on Activities of Daily Living Questionnaire
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 13:705-12. 2011
  10. ncbi Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 9:89-98. 2007

Collaborators

Detail Information

Publications20

  1. doi Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Diabetes 5:358-67. 2013
    ..Herein we explore factors contributing to decreased insulin therapy self-efficacy in insulin-naïve patients with type 2 diabetes mellitus (T2DM) initiating and managing insulin therapy over 36 weeks...
  2. pmc Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Lars Viktrup
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    BMC Urol 12:30. 2012
    ..The aim of this study was to provide evidence of the validity of the 1-item Patient Global Impression of Severity (PGI-S) and Improvement (PGI-I) questionnaires for use as outcome measures in the treatment of BPH-LUTS...
  3. doi Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA
    Diabetes Technol Ther 14:1118-25. 2012
    ..The primary objective of this study was to estimate APPADL test-retest reliability, responsiveness, and minimal important change (MIC)...
  4. pmc Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
    Kristina Secnik Boye
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Health Qual Life Outcomes 4:80. 2006
    ....
  5. pmc Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
    Mallik Angalakuditi
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, IN, USA
    Health Qual Life Outcomes 8:131. 2010
    ..To assess the measurement properties of the Benign Prostatic Hyperplasia Impact Index (BII) for use in men with Lower Urinary Tract Symptoms (LUTS) secondary to Benign Prostatic Hyperplasia (BPH) treated with tadalafil...
  6. pmc Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
    R P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA
    Int J Clin Pract 62:860-8. 2008
    ..Yet, there is reluctance among physicians, specifically primary care physicians (PCPs) in the USA, to initiate insulin therapy in these patients...
  7. doi Perceptions and attitudes are primary contributors to insulin delivery system satisfaction in people with type 2 diabetes
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 11:419-26. 2009
    ..This study identifies factors that influence satisfaction with an insulin delivery system (IDS). Knowledge of such factors could help identify individuals who would benefit from innovative IDS...
  8. doi The contribution of pretreatment expectations and expectation-perception difference to change in treatment satisfaction and end point treatment satisfaction in the context of initiation of inhaled insulin therapy in patients with type 2 diabetes
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 12:447-53. 2010
    ....
  9. doi Ability to perform daily physical activities in individuals with type 2 diabetes and moderate obesity: a preliminary validation of the Impact of Weight on Activities of Daily Living Questionnaire
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 13:705-12. 2011
    ....
  10. ncbi Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Diabetes Technol Ther 9:89-98. 2007
    ..Inhaled insulin may provide patients with diabetes a safe, efficacious method of insulin delivery without the burden of injection, but complexity of and time required for training in proper use of delivery systems have not been evaluated...
  11. ncbi Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes
    Risa P Hayes
    Global Health Outcomes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Curr Med Res Opin 23:435-42. 2007
    ....
  12. ncbi The effect of external feedback on the management of medicare inpatients with congestive heart failure
    Risa P Hayes
    Kerr L White Institute for Health Services Research, Decatur, GA, USA
    Am J Med Qual 17:225-35. 2002
    ..01). Evaluation of the effects of external feedback on practice behavior requires sufficient time for organizational and individual clinician change to occur. Physician liaisons may play a role in facilitating this change...
  13. ncbi Comparison of an enhanced versus a written feedback model on the management of Medicare inpatients with venous thrombosis
    R Hayes
    Kerr L White Institute for Health Services Research, USA
    Jt Comm J Qual Improv 27:155-68. 2001
    ....
  14. ncbi Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance
    Risa P Hayes
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Diabetes Educ 32:404-14. 2006
    ..The purpose of this qualitative study was to explore diabetes medication experiences of patients with type 2 diabetes...
  15. pmc Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
    A N Naegeli
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA
    Int J Clin Pract 64:908-16. 2010
    ..The aim of this study was to investigate how patients' expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction...
  16. ncbi The Improving Primary Care of African Americans with Diabetes (IPCAAD) project: rationale and design
    Lawrence S Phillips
    Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Control Clin Trials 23:554-69. 2002
    ..We will compare two readily generalizable program interventions that should delineate approaches effective in a primary care setting as needed to improve care and prevent complications in urban African Americans with type 2 diabetes...
  17. ncbi Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment
    Stephanie Studenski
    Department of Medicine, Geriatrics Division, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Am Geriatr Soc 52:1560-6. 2004
    ..To expand the ability to assess physical frailty by developing a Clinical Global Impression of Change in Physical Frailty (CGIC-PF) instrument...
  18. ncbi An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7
    Lawrence S Phillips
    Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    Diabetes Care 28:2352-60. 2005
    ..We asked whether interventions targeting clinical inertia can improve outcomes...
  19. ncbi Preference and compliance in postoperative thromboembolism prophylaxis among gynecologic oncology patients
    G Larry Maxwell
    Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Obstet Gynecol 100:451-5. 2002
    ....
  20. ncbi The effect of self-reported and performance-based functional impairment on future hospital costs of community-dwelling older persons
    David B Reuben
    Multicampus Program in Geriatric Medicine and Gerontology, David Geffen School of Medicine at the University of California Los Angeles, 90095 1687, USA
    Gerontologist 44:401-7. 2004
    ..We determined the prognostic value of self-reported and performance-based measurement of function, including functional transitions and combining different measurement approaches, on utilization...